GYNECOLOGIC ONCOLOGY (PRINT)

Qualis

• A1

código do país

• NL

tipo

• journal

publicação venue de

• Can mismatch repair status be added to sentinel lymph node mapping algorithm in endometrioid endometrial cancer?.  169:131-136. 2023-01-01
• EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.  170:114-122. 2023-01-01
• Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.  170:179-185. 2023-01-01
• Presentation,medical complications and development of gestational trophoblastic neoplasia or hydatiform mole after intracytoplasmatic sperm injection as compared to hydatiform mole after spontaneous conception.  170:179-185. 2023-01-01
• Profiling the immune landscape in mucinous ovarian carcinoma.  168:23-31. 2023-01-01
• Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.  170:195-202. 2023-01-01
• Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project.  168:151-156. 2023-01-01
• The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.  176:130-138. 2023-01-01
• Clear cell carcinoma of the endometrium.  163:1. 2022-01-01
• Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.  165:82-89. 2022-01-01
• Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism.  165:137-142. 2022-01-01
• Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.  164:514-521. 2022-01-01
• Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal.  165:642-649. 2022-01-01
• Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.  X:X. 2022-01-01
• Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer.  1:ONLINE. 2022-01-01
• Post-recurrence survival in patients with cervical cancer.  164:362-369. 2022-01-01
• A proof-of-concept randomized phase 2 non-inferiority trial on simple versus modified radical hysterectomy in IA2-IB1 cervical cancer ≤2cm (LESSER).  162:S36-S37. 2021-01-01
• Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?.  162:638-644. 2021-01-01
• Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial.  160:379-383. 2021-01-01
• Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study.  14:526. 2021-01-01
• Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.  1:1-280. 2021-01-01
• Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis.  1:1-1. 2021-01-01
• Uterine serous carcinoma.  162:226-234. 2021-01-01
• Clinical Relevance of Co-Expression of HLA-DRα, CD74/II and NFkB in Epithelial Ovarian Cancer: Identification of Prognostic and Therapeutical Biomarker Profile.  2:115-121. 2020-01-01
• Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemoterapy on the weekend.  156:598-605. 2020-01-01
• Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.  156:598-605. 2020-01-01
• Development of a screening tool to improve the referral of patients with breast and gynecological cancer to outpatient palliative care.  158:1-157. 2020-01-01
• Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.  157:372-378. 2020-01-01
• Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study.  158:31014-3-459. 2020-01-01
• Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.  -:1-2. 2020-01-01
• Oncology treatments in reproductive age cancer patients: The effect of treatment failure and recurrence on fertility risk assessment.  159:308-x. 2020-01-01
• Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.  1-8. 2020-01-01
• Primary results from CECILIA, aglobal single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.  159:142-149. 2020-01-01

tem uma área de assunto

• BIOTECNOLOGIA
• CIENCIAS BIOLOGICAS I
• CIENCIAS BIOLOGICAS II
• CIENCIAS BIOLOGICAS III
• FARMACIA
• MEDICINA I
• MEDICINA II
• MEDICINA III
• SAUDE COLETIVA

publisher

• Elsevier BV

is open access

• False invalid format

is in DOAJ

• False invalid format

2 year mean citedness

• 1.6948955916473318

H index

• 194

i10 index

• 11031

ISSN-L

• 0090-8258

openalex identifier

• https://openalex.org/S2574783

International Standard Serial Number (ISSN)

• 0090-8258
• 1095-6859